AT Skarin
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Viral-associated cancers and disorders
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 3
- Oncology 4
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 1
- Viral-associated cancers and disorders 1
- Co-authors
- Ravi Salgia (1 shared paper)Steven E. Come (1 shared paper)G P Canellos (1 shared paper)David I. Rosenthal (1 shared paper)P Mauch (1 shared paper)H Weinstein (1 shared paper)N.J. Tarbell (1 shared paper)Michael L. Grossbard (2 shared papers)
- Journals
- Lung Cancer (3 papers)Journal of Clinical Oncology (2 papers)PubMed (3 papers)
- Partner nations
- United States
In The Last Decade
AT Skarin
8 papers receiving 303 citations
Peers
Comparison fields: 5 of 44
- Pathology and Forensic Medicine 108
- Oncology 158
- Pulmonary and Respiratory Medicine 128
- Genetics 41
- Cancer Research 40
Countries citing papers authored by AT Skarin
This map shows the geographic impact of AT Skarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AT Skarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AT Skarin more than expected).
Fields of papers citing papers by AT Skarin
This network shows the impact of papers produced by AT Skarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AT Skarin. The network helps show where AT Skarin may publish in the future.
Co-authors
The 25 scholars most cited alongside AT Skarin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 214 | |
| 2 | 1987 | 55 | |
| 3 | Chemotherapy in the treatment of Hodgkin's disease. | 1983 | 33 |
| 4 | Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis. | 1997 | 4 |
| 5 | Chemotherapy (CAP) prior to radiotherapy (RT) and surgery in marginally resectable stage III M0 non-small cell lung cancer. | 1985 | 4 |
| 6 | 2000 | 3 | |
| 7 | 2000 | 3 | |
| 8 | 2005 | 2 |
About AT Skarin
AT Skarin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Pathology and Forensic Medicine and Epidemiology, having authored 8 papers that have together received 318 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Research Studies (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Neuroendocrine Tumor Research Advances (1 paper), Cancer Treatment and Pharmacology (1 paper) and Viral-associated cancers and disorders (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (108 citations), Oncology (158 citations), Pulmonary and Respiratory Medicine (128 citations), Genetics (41 citations) and Cancer Research (40 citations). AT Skarin has collaborated with scholars based in United States. Frequent co-authors include Ravi Salgia, Steven E. Come, G P Canellos, David I. Rosenthal, P Mauch, H Weinstein, N.J. Tarbell, Michael L. Grossbard, Thomas J. Lynch and E Frei. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.